Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,641 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07228611Recruiting
Osteoporosis risk after stroke
This study looks at bone health in people who have had a stroke. It aims to find out who is at risk for weak bones (osteoporosis) after a stroke, so doctors can help prevent fractures.
Ankara, YenimahalleAges 55–85 - NCT04163133Recruiting
Timing changes during ovarian stimulation for IVF
This study tests whether changing the timing of hormones during ovarian stimulation can improve IVF results for people with certain ovarian reserve levels. It may help find a stimulation approach that works better for first-time (or second) IVF cycles.
Beijing, Beijing MunicipalityAges 18–42 - NCT05767164Recruiting
Study links surgery outcomes to test results in cervical spine disease
This study looks at how measurements from symptoms, exams, and MRI results relate to recovery after a specific type of neck surgery (“single open-door” surgery). It may help doctors better predict who is more likely to do well after this operation.
Xi'an, Shannxi ProvinceAges 18–86 - NCT06526767Recruiting
Vibrating capsule for chronic constipation dose comparison
This study tests three different doses of a vibrating capsule (Vibrabot) to see which works best for relieving chronic constipation. If you have had constipation for at least 6 months and meet the Rome IV criteria, you may be able to join.
Beijing, Beijing MunicipalityAges 18–85 - NCT06962410Recruiting
Hybrid Closed-Loop for Diabetes After Kidney Transplant
This trial tests a hybrid closed-loop system (an advanced insulin pump that automatically adjusts insulin) for people with diabetes who have had a kidney transplant. It may help improve blood sugar control and reduce the burden of managing diabetes after transplant.
Taiyuan, ShanxiAges 18–70 - NCT06527482Recruiting
Using your own bone and cartilage to repair ankle damage
This trial tests a surgery that takes a small piece of bone and cartilage from your knee and transplants it to a damaged area in your ankle. It may help people with severe ankle cartilage injuries that haven't gotten better with other treatments.
BeijingAges 18–60 - NCT06528028RecruitingPhase 4
Ceftazidime/avibactam regimens and outcomes
This trial compares different ways of giving the antibiotic ceftazidime/avibactam to see which works best. It is for people with infections caused by a type of bacteria that is hard to treat (called multidrug-resistant) but still responds to this medicine.
Nanjing, JiangsuAges 18–80 - NCT06839404Recruiting
Fluid bolus effect on heart and blood flow
This study looks at how a standard IV fluid bolus affects blood flow and heart function in ICU patients. It aims to better understand the body's response to this common treatment.
Le Kremlin-BicêtreAges 18 years+ - NCT06528197Recruiting
Building a better treatment model for Sjögren's syndrome
This study is building a new model to help doctors treat primary Sjögren's syndrome using a combination of traditional Chinese medicine and Western medicine. It may help find better ways to manage your symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT07225244Recruiting
Comparing balloon inflation points for tear duct surgery
This trial tests whether using four balloon inflation points during tear duct surgery works better than the standard two points for people with blocked tear ducts. It aims to improve tear drainage and reduce symptoms.
TaipeiAges 20 years+ - NCT07270770RecruitingPhase 1
A New Drug BY002 for Relapsed Acute Leukemia with Genetic Changes
This phase 1 trial tests a new drug called BY002 for people with certain types of leukemia (AML, ALL, or MPAL) that have come back or not responded to treatment. It focuses on patients whose leukemia has a specific genetic change (KMT2A rearrangement or NPM1 mutation). The goal is to see if BY002 can help control the disease.
Suzhou, JiangsuAges 16 years+ - NCT07015554Enrolling by invitation
IGF1 levels in women with heart failure
This study looks at a hormone called IGF1 in women with a specific type of heart failure (where the heart pumps normally but is stiff). It may help understand if this hormone is linked to the condition.
Shenzhen, GuangdongAges 18 years+ - NCT05773651Recruiting
Study for rare solid tumors in children and teens
This study collects information from children and teens with rare solid tumors to better understand these cancers and support future research. You (or your guardian) can join by giving consent, but it’s mainly for people not already registered in certain ongoing pediatric cancer study databases in Germany.
TübingenAges 1 day–18 years - NCT05260619RecruitingPhase 2
Lenalidomide after response for primary brain lymphoma
This trial studies lenalidomide taken after your first treatment has worked for primary central nervous system lymphoma (PCNSL). It aims to help keep the lymphoma from coming back by testing lenalidomide as ongoing “maintenance” treatment.
Seongnam-si, Please SelectAges 19 years+ - NCT07220486Recruiting
Depression support program for nursing home residents and their helpers
This study tests a program for nursing facility residents who have symptoms of depression and their care partners. It aims to provide emotional and practical support during a short stay.
Boston, MassachusettsAges 18 years+ - NCT04924998Recruiting
Study for AL-CM treatment in adults at one hospital
This study is looking at a treatment approach for people diagnosed with AL-CM at a specific hospital. It may help researchers understand whether the treatment is safe and effective for patients like you.
Hangzhou, ZhejiangAges 18–80 - NCT06821490Enrolling by invitation
TAD biopsy for HER2+ breast cancer with positive lymph nodes
This trial tests the accuracy of a targeted axillary dissection (TAD) after chemotherapy in people with HER2+ breast cancer that has spread to the lymph nodes. It aims to see if the TAD method can correctly identify which lymph nodes are cancer-free before surgery.
Valencia, ValenciaAges 18 years+ - NCT07217964Enrolling by invitation
Study of natural protein for spinal fusion surgery
This trial is testing a natural protein material used during spinal fusion surgery to treat lower back pain caused by worn-out discs. It may help patients who haven't gotten better with other treatments and need surgery on up to four levels of the lower spine.
New York, New YorkAges 18 years+ - NCT05514015RecruitingPhase 4
Rituximab with steroids or rituximab alone for membranous kidney disease
This trial studies how well rituximab works in primary membranous nephropathy (a kidney condition) either by itself or with corticosteroids (steroids). It aims to see which approach controls protein leakage in the urine and protects kidney function.
Guangzhou, GuangdongAges 18–75 - NCT06802042Recruiting
Probiotic for constipation in pregnancy
This trial tests if a probiotic called Lactobacillus can help relieve constipation in pregnant women and improve gut health. It compares the probiotic to a placebo to see if it is safe and effective.
Beijing, Beijing MunicipalityAges 18–40 - NCT06531434RecruitingPhase 1/Phase 2
Best treatment plan for advanced esophageal cancer
This trial is for people with T4 esophageal cancer, where the tumor has spread to nearby organs. It aims to find the best treatment approach to improve outcomes.
Tainan, TaiwanAges 18–70 - NCT07217080Enrolling by invitation
Thalamic stimulation's effect on sleep brain waves
This trial studies how electrical stimulation in a deep brain area called the thalamus affects sleep brain waves. It may help people who already need brain recordings for medical reasons.
Boston, MassachusettsAges 5–85 - NCT06919133Enrolling by invitation
Using smartphone markers to manage depression symptoms
This study tests whether using a smartphone app to track your mood and behavior can help you manage depression symptoms better. You'll use digital tools to monitor your own progress and learn self-management strategies.
FrederiksbergAges 18 years+ - NCT05734794RecruitingPhase 3
Rituximab for new childhood nephrotic syndrome
This trial studies whether rituximab alone can help children with new-onset idiopathic nephrotic syndrome. It compares the treatment approach in order to see if it improves kidney recovery and reduces disease activity.
Hangzhou, ZhejiangAges 2–17
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,641 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.